Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Esoterix Oncology is a specialized laboratory services provider that offers comprehensive oncology testing, including hematopathology, flow cytometry, cytogenetics, and molecular diagnostics. Formerly known as Cytometry Associates, the company was a division of Esoterix, Inc., which was acquired by LabCorp in 2005 for approximately $150 million. It serves hospitals, oncologists, and biopharmaceutical companies by providing high-end esoteric cancer diagnostic services and supporting clinical trials. The company is recognized for its expertise in complex testing disciplines and its role in precision medicine and oncology research. Today, its services are integrated into LabCorp's broader oncology and specialty testing portfolio, often operating under the Integrated Oncology brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Esoterix Oncology.